Stephen Oesterle

Between 2002 and 2015, Stephen was a member of Medtronic’s Executive Committee, serving as Senior Vice President for Medicine and Technology. In this role, he contributed to the company’s business development, operating plans and long-term strategies. In addition, Stephen had corporate oversight of Medtronic’s technology R&D, developing and leading collaborative relationships with technical universities, high tech corporations and medical device start-ups.

Prior to this, Stephen served as Associate Professor of Medicine at the Harvard University Medical School and as Director of Invasive Cardiology Services at Massachusetts General Hospital, Boston. As a teacher and innovator in the field of cardiac catheterization, he also developed and directed interventional cardiology programmes at Good Samaritan Hospital, Los Angeles, as well as at the universities of Georgetown and Stanford.

Stephen is independent director on several public and private boards in the USA, Switzerland, Germany and China.

Stephen serves on a wide range of boards, including Baxter International (NYSE), Peijia Medical (Shanghai) Paragon 28 (NYSE), Private equity backed SHL Medical AG (Zürich) and  CeramTec (Germany) and venture backed Alcyone Therapeutics and Anuncia.